Inhibikase Therapeutics
IKT
#8388
Rank
S$0.41 B
Marketcap
S$2.94
Share price
-3.35%
Change (1 day)
44.04%
Change (1 year)

Inhibikase Therapeutics (IKT) Fails to deliver data

Key failure to deliver metrics for Inhibikase Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Inhibikase Therapeutics (IKT) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Inhibikase Therapeutics (IKT) - since 2023

Volume in USD (price x number of shares), data since 2023

Inhibikase Therapeutics (IKT) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026S$4.22 M-40.85%
2025S$7.14 M106.3%
2024S$3.46 M566.7%
2023S$0.51 M